ArticleJournal of nanobiotechnology2026

Development of VP30-targeted nanoparticles using DPS4 fusion peptides for the inhibition of Ebola virus.

Fang Wu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.